Skip to main content
Premium Trial:

Request an Annual Quote

Kate Black

23andMe has appointed Kate Black as its new privacy officer and corporate counsel. Black previously worked as a federal regulatory and interoperability policy analyst at the Office of the National Coordinator for Health Information Technology of the United States Department of Health and Human Services. She also has served as health privacy counsel for the Center for Democracy and Technology in San Francisco. Black will report to Kathy Hibbs, chief legal and regulatory affairs officer of 23andMe, and will be responsible for reviewing, updating, and enhancing the company's privacy and consent policies for customers.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.